Cite
HARVARD Citation
Imaz, A. et al. (2014). Effectiveness of Efavirenz Compared with Ritonavir-Boosted Protease-Inhibitor-Based Regimens as Initial Therapy for Patients with Plasma HIV-1 RNA above 100, 000 Copies/Ml. Antiviral therapy. 19 (6), pp. 569-577. [Online].